Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $34.1000 (6.23%) ($31.5000 - $35.0000) on Mon. Jun. 13, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.32% (three month average) | RSI | 57 | Latest Price | $34.1000(6.23%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 1.1% a day on average for past five trading days. | Weekly Trend | CAPR advances 3.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(8%) SKYY(8%) ARKK(7%) EWG(7%) EWI(7%) | Factors Impacting CAPR price | CAPR will decline at least -2.66% in a week (0% probabilities). VIXM(-5%) TLT(-5%) GLD(-5%) SLV(-4%) GDX(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.66% (StdDev 5.32%) | Hourly BBV | 0 () | Intraday Trend | 0.6% | | | |
|
5 Day Moving Average | $34.54(-1.27%) | 10 Day Moving Average | $33.21(2.68%) | 20 Day Moving Average | $33(3.33%) | To recent high | -18.2% | To recent low | 55.3% | Market Cap | $672m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |